A 198401

Drug Profile

A 198401

Latest Information Update: 24 Jan 2013

Price : $50

At a glance

  • Originator Abbott Laboratories
  • Developer Abbott Laboratories; Takeda; TAP Pharmaceutical Products
  • Class Antihormones
  • Mechanism of Action Gonadotropin releasing hormone inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Discontinued Female infertility

Most Recent Events

  • 11 Mar 2003 No development reported - Preclinical for Female infertility in USA (Vaginal)
  • 14 Aug 2001 A preclinical study has been added to the pharmacokinetics and Endocrine Disorders pharmacodynamics sections
  • 25 Nov 1999 Preclinical development for Female infertility in USA (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top